Calamos Wealth Management LLC Acquires Shares of 2,208 Molina Healthcare, Inc $MOH

Calamos Wealth Management LLC acquired a new position in shares of Molina Healthcare, Inc (NYSE:MOH) during the 1st quarter, according to its most recent 13F filing with the SEC. The fund acquired 2,208 shares of the company’s stock, valued at approximately $294,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of MOH. 7G Capital Management LLC bought a new stake in shares of Molina Healthcare in the fourth quarter worth $1,735,000. BNP Paribas Financial Markets boosted its stake in Molina Healthcare by 63.0% during the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock valued at $76,248,000 after acquiring an additional 169,739 shares during the last quarter. Assenagon Asset Management S.A. boosted its stake in Molina Healthcare by 241.2% during the 4th quarter. Assenagon Asset Management S.A. now owns 271,224 shares of the company’s stock valued at $47,068,000 after acquiring an additional 191,731 shares during the last quarter. Prana Capital Management LP acquired a new position in Molina Healthcare during the 3rd quarter worth $5,242,000. Finally, Allspring Global Investments Holdings LLC grew its holdings in Molina Healthcare by 27.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 38,913 shares of the company’s stock worth $6,944,000 after acquiring an additional 8,381 shares in the last quarter. 98.50% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on MOH shares. Wells Fargo & Company upped their target price on shares of Molina Healthcare from $159.00 to $235.00 and gave the company an “equal weight” rating in a research note on Monday. Royal Bank Of Canada lifted their price target on Molina Healthcare from $216.00 to $248.00 and gave the stock a “sector perform” rating in a research note on Thursday, July 9th. Mizuho set a $215.00 price objective on Molina Healthcare in a report on Monday, June 8th. UBS Group upped their price objective on Molina Healthcare from $180.00 to $202.00 and gave the company a “neutral” rating in a research note on Friday, May 22nd. Finally, Truist Financial increased their target price on Molina Healthcare from $205.00 to $250.00 and gave the stock a “hold” rating in a report on Tuesday. Three research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $207.06.

Molina Healthcare Stock Down 3.4%

Shares of NYSE:MOH opened at $233.44 on Thursday. The company’s fifty day moving average is $201.97 and its two-hundred day moving average is $174.74. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. Molina Healthcare, Inc has a 1-year low of $121.06 and a 1-year high of $244.89. The stock has a market capitalization of $12.16 billion, a price-to-earnings ratio of 69.07 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The business had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the business posted $6.08 EPS. The company’s quarterly revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts anticipate that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Transactions at Molina Healthcare

In other news, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the transaction, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Maurice Hebert sold 600 shares of the stock in a transaction that occurred on Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.